New York Attorney General Eric Schneiderman today applauded the U.S. Supreme Court’s decision that pay-for-delay settlements of drug-patent litigation may be challenged as potential violations of antitrust law.
The ruling is a “victory” for millions of Americans who depend on generic drugs to treat illness and pain, Schneiderman said in the news release.
“As we argued in our brief to the Supreme Court, pay-for-delay drug settlements should receive serious scrutiny because they are frequently anticompetitive, unlawful, and harmful to health-care consumers across the country. This decision makes clear that drug companies can be sued to stop anticompetitive pay-for-delay agreements. It will be an important weapon in the fight for affordable drug prices and quality healthcare for every citizen,” Schneiderman said.
(Sponsored)
Ask the Expert: How Registered Apprenticeship Can Solve Employers’ Workforce Challenges
In today’s tight labor market, finding and retaining skilled workers is tougher than ever. Many industries are facing talent shortages, rising turnover costs, and the pressure to keep pace with
It’s Time for Your Business to Think About Year-End Tax Planning
As the year-end approaches, it’s time to take proactive steps to help lower your business’s taxes for 2024 and beyond. Deferring income and accelerating deductions to minimize taxes can be
Schneiderman in January led a coalition of 36 states, plus the District of Columbia and the Commonwealth of Puerto Rico, in arguing that the Supreme Court should allow antitrust enforcers to challenge pay-for-delay settlements as anticompetitive and unlawful, according to the news release.
Contact Reinhardt at ereinhardt@cnybj.com
